HealthQuill Japan
The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More
BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a rare heart disease condition has yielded positive results.
Drugs Health Pharma

BridgeBio says oral drug to treat rare heart disease meets trial goal

HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.

Read More
Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority for leqembi, an investigational drug to treat early onset of Alzheimer’s disease.
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
A combination of flesh-eating bacteria, brown seaweed, and plastics in the ocean can potentially create a “pathogen storm” affecting both marine life and public health, according to researchers from Florida Atlantic University.
Climate Health Pharma

A potential ‘pathogen storm’ is brewing up in the oceans

HQ Team May 22, 2023: A combination of flesh-eating bacteria, brown seaweed, and plastics in the ocean can potentially create a “pathogen storm”.

Read More
Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment of hot flushes in menopausal women.
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More
Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise in sea levels, and human displacement last year,  according to a WMO report. 
Climate Drugs Health

Failing crops, melting glaciers, record-smashing heat in 2022: WMO

HQ Team April 22, 2023: Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise.

Read More
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs Pharma

Eiasi files market authorization for Alzheimer’s drug in Japan

Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.

Read More
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Drugs Pharma

FDA gives accelerated approval for Alzheimer’s drug

The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.

Read More
The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest Covid-19 lockdown.
Drugs Health Medical

WHO tells China to share Covid-19 data in real-time

The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest.

Read More
Adani Energy
Climate

Adani Energy raises JPY 27.9 billion to refinance debt

Adani Green Energy has raised a JPY 27.9 billion ($200 million) loan from two Japanese banks to refinance its existing debt.

Read More
X